AÇÃO DO LÚPULO EM PACIENTES QUE FAZEM USO DE MEDICAMENTOS PSICOTRÓPICOS
DOI:
https://doi.org/10.61164/rmnm.v6i1.2588Palabras clave:
Hops; interaction; Medicinal Properties; TreatmentResumen
Este estudo explora a interação do lúpulo (Humulus lupulus) com medicamentos psicotrópicos, destacando seus potenciais benefícios terapêuticos e os riscos associados. O lúpulo, conhecido por suas propriedades sedativas e ansiolíticas devido a compostos como alfa-ácidos e 8-prenilnaringenina, pode ser usado para tratar distúrbios de ansiedade e insônia. No entanto, quando combinado com medicamentos psicotrópicos como antidepressivos e ansiolíticos, há o potencial de potencializar os efeitos sedativos, aumentando o risco de sedação excessiva e comprometimento cognitivo. Além disso, o lúpulo pode influenciar a farmacocinética dos medicamentos, alterando sua absorção e metabolismo através do sistema citocromo P450. Este estudo destaca a necessidade de monitoramento clínico rigoroso ao considerar a combinação de lúpulo e medicamentos psicotrópicos, visando maximizar os benefícios terapêuticos enquanto minimiza os riscos para a saúde dos pacientes.
Descargas
Referencias
Stahl, S. M. (2013). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press.
• G1. (1 de abril de 2024). Da cerveja à medicina: Entenda como lúpulo pode ser usado contra os vírus chikungunya e oropouche. Recuperado de G1.
• Bhattacharyya, S., Sharma, V. K., & Sharma, A. (2011). Medicinal Properties of Humulus Lupulus L. (Hops): A Review. Indian Journal of Natural Products and Resources, 2(3), 292-299.
• Jones, M. (2020). Herbal Interactions with Psychotropic Medications: A Review. Journal of Clinical Pharmacology, 60(5), 570-580. DOI:10.1002/jcph.1598.
• Stevens JF, Page JE. Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry. 2004;65(10):1317-1330.
• Miranda CL, Stevens JF, Helmrich A, et al. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem Toxicol. 1999;37(4):271-285. PubMed
• Zanoli P, Zavatti M. Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol. 2008;116(3):383-396.
• Gerhäuser C. Broad spectrum anti-infective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites. Mol Nutr Food Res. 2005;49(9):827-831.
• Chadwick LR, Pauli GF, Farnsworth NR. The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine. 2006;13(1-2):119-131.
• Erkkola R, Vervarcke S, Vansteelandt S, Rompotti P, De Keukeleire D. A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts. Phytomedicine. 2010;17(6):389-396.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2024 Revista Multidisciplinar do Nordeste Mineiro

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
